Patents Assigned to Ashmont Holdings Limited
  • Injectable compositions
    Patent number: 6663879
    Abstract: A stable injectable composition includes a non-aqueous parasitic agent in a therapeutically effect amount, chosen from the group of avermectin, ivermectin, doramectin, abamectin, milbemycin and moxidecting, and an antigen in combination with a liquid carrier that also acts as an adjuvant for use with warm blooded animals and a method for treating parasitic diseases and preventing bacterial and viral diseases in warm blooded animals.
    Type: Grant
    Filed: February 21, 2001
    Date of Patent: December 16, 2003
    Assignee: Ashmont Holdings Limited
    Inventor: Colin Manson Harvey
  • Injectable compositions
    Publication number: 20010014336
    Abstract: A stable injectable composition includes a non-aqueous parasitic agent in a therapeutically effect amount, chosen from the group of avermectin, ivermectin, doramectin, abamectin, milbemycin and moxidecting, and an antigen in combination with a liquid carrier that also acts as an adjuvant for use with warm blooded animals and a method for treating parasitic diseases and preventing bacterial and viral diseases in warm blooded animals.
    Type: Application
    Filed: February 21, 2001
    Publication date: August 16, 2001
    Applicant: Ashmont Holdings Limited
    Inventor: Colin Manson Harvey
  • Injectable compositions
    Patent number: 6214367
    Abstract: A stable injectable composition includes a non-aqueous parasitic agent in a therapeutically effect amount, chosen from the group of avermectin, ivermectin, doramectin, abamectin, milbemycin and moxidecting, and an antigen in combination with a liquid carrier that also acts as an adjuvant for use with warm-blooded animals and a method for treating parasitic diseases and preventing bacterial and viral diseases in warm-blooded animals.
    Type: Grant
    Filed: December 31, 1998
    Date of Patent: April 10, 2001
    Assignee: Ashmont Holdings Limited
    Inventor: Colin Manson Harvey
  • Anthelmintic macrocyclic lactone compositions
    Patent number: 6013636
    Abstract: A composition comprising an anthelmintic chosen from the class of macrocyclic lactones including but not limited to the avermectins, ivermectin, doramectin, abamectin, milbemycin and moxidectin, together with a vegetable oil and a co-solvent chosen from the group comprising alcohols having four or more carbons atoms. The compositions of the inventions may be formulated as injections, drenches or for topical administration and are suitable for treating helminthiasis in animals.
    Type: Grant
    Filed: March 25, 1998
    Date of Patent: January 11, 2000
    Assignee: Ashmont Holdings Limited
    Inventor: Colin Manson Harvey